Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Duvoux

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Journal of Personalized Medicine|October 28, 2025
Hepatocellular Carcinoma Transplant Criteria Show Poor Negative Predictive Value: A Systematic Review and Meta-AnalysisLaura P Frazão, Margarida C Quaresma, José B Pereira-Leal, et al.
The Journal of Rheumatology|January 6, 2004
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or COwonayo Oniankitan, Christophe Duvoux, Dominique Challine, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 19, 2024
Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER randomized clinical trialFederico Piñero, Quirino Lai, Charlotte Costentin, et al.
Clinics and Research in Hepatology and Gastroenterology|June 25, 2023
Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in FranceAudrey Coilly, Carine Jasseron, Camille Legeai, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2020
Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapyClément Barjon, Géraldine Dahlqvist, Khaldoun Ghazal, et al.
Journal of Hepatology|May 24, 2003
Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosisCatherine Leroy-Matheron, Christophe Duvoux, Jeanne Tran Van Nhieu, et al.
Transplantation|June 17, 2020
Socioeconomic Deprivation Does Not Impact Liver Transplantation Outcome for HCC: A Survival Analysis From a National DatabaseBenjamin Menahem, Olivier Dejardin, Arnaud Alves, et al.
Intensive Care Medicine|April 5, 2003
Effect of severe thrombocytopenia on patient outcome after liver transplantationChaker Ben Hamida, Jean-Yves Lauzet, Saida Rézaiguia-Delclaux, et al.
Transplantation|December 14, 2006
Successful reuse of liver graft 13 years after initial transplantationClaude Tayar, Mehdi Karoui, Alexis Laurent, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 16, 2017
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysisBenjamin Menahem, Jean Lubrano, Christophe Duvoux, et al.
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Journal of Personalized Medicine|October 28, 2025
Hepatocellular Carcinoma Transplant Criteria Show Poor Negative Predictive Value: A Systematic Review and Meta-AnalysisLaura P Frazão, Margarida C Quaresma, José B Pereira-Leal, et al.
The Journal of Rheumatology|January 6, 2004
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or COwonayo Oniankitan, Christophe Duvoux, Dominique Challine, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 19, 2024
Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER randomized clinical trialFederico Piñero, Quirino Lai, Charlotte Costentin, et al.
Clinics and Research in Hepatology and Gastroenterology|June 25, 2023
Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in FranceAudrey Coilly, Carine Jasseron, Camille Legeai, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2020
Influence of everolimus-based treatment on circulating regulatory T cells after liver transplantation: Comparative study with tacrolimus-based therapyClément Barjon, Géraldine Dahlqvist, Khaldoun Ghazal, et al.
Journal of Hepatology|May 24, 2003
Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosisCatherine Leroy-Matheron, Christophe Duvoux, Jeanne Tran Van Nhieu, et al.
Transplantation|June 17, 2020
Socioeconomic Deprivation Does Not Impact Liver Transplantation Outcome for HCC: A Survival Analysis From a National DatabaseBenjamin Menahem, Olivier Dejardin, Arnaud Alves, et al.
Intensive Care Medicine|April 5, 2003
Effect of severe thrombocytopenia on patient outcome after liver transplantationChaker Ben Hamida, Jean-Yves Lauzet, Saida Rézaiguia-Delclaux, et al.
Transplantation|December 14, 2006
Successful reuse of liver graft 13 years after initial transplantationClaude Tayar, Mehdi Karoui, Alexis Laurent, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 16, 2017
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysisBenjamin Menahem, Jean Lubrano, Christophe Duvoux, et al.
Pageof 16